QVMS
Invesco S&P SmallCap 600 QVM Multi-factor ETF
QVMS tracks a market-cap-weighted index of small-cap companies in the US that exhibit quality, value and momentum factors.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 239.3 M
ASSETS UNDER MGMT
15 bp
EXPENSES
Fund Basics
| Inception date | Jun 30, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| SANMINA CORP | 1.0 % |
| SEMTECH CORP | 0.9 % |
| FORMFACTOR INC | 0.8 % |
| STONEX GROUP INC | 0.7 % |
| VIAVI SOLUTIONS INC. | 0.7 % |
| KRYSTAL BIOTECH, INC. | 0.6 % |
| PLATFORM SPECIALTY PRODUCTS | 0.6 % |
| EASTMAN CHEMICAL COMPANY | 0.6 % |
| ESCO TECHNOLOGIES INC | 0.6 % |
| VICTORIA'S SECRET & COMPANY | 0.6 % |
Constituent Breakdown
| Number of holdings | 531 |
| Herfindahl-Hirschman Index | 29 |
| Wgt avg mkt cap (mns) | $4,259 |
| Large cap (>$10bn) | 3.6% |
| Mid cap ($2-10bn) | 76.7% |
| Small cap (<$2bn) | 16.4% |
| Developed mkts. | 97.3% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 95.3 % |
 |
IRELAND | 0.7 % |
 |
BERMUDA | 0.6 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 13.5% | 14.6% | 8.3% | 13.7% | 5.7% | -- | -- | 4.8% |
| Dividend Yield | 1.2% | 1.6% | 1.5% | 1.6% | 1.6% | -- | -- | 1.5% |
| Total Returns | 14.7% | 16.2% | 9.8% | 15.3% | 7.3% | -- | -- | 6.4% | Ann. Volatility | 16.3% | 16.7% | 20.3% | 20.3% | 21.0% | -- | -- | 20.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.97 | 57% |
| MSCI EAFE | 0.74 | 50% |
| MSCI Emg Mkts | 0.41 | 38% |
Liquidity Measures
| Avg. volume (000) | 1 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.23% |
Technical Indicators
| 30d moving avg. (EMA) | $34.54 |
| Relative strength (RSI) | 61 |
| MACD/Signal | 0.32/0.27 |
| Bollinger Bands (Upper/Lower) | $35.59/$33.68 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. QVMS |
Expenses vs. QVMS |
ALTAR Score™ vs. QVMS |
|---|---|---|---|---|
| VIOO | Vanguard S&P Small-Cap 600 ETF | 76.1% | -8 bp | -0.1% |
| SPSM | State Street SPDR Portfolio S&P 600 Small Cap ETF | 74.4% | -12 bp | +0.2% |
| IJR | iShares Core S&P Small Cap ETF | 73.5% | -9 bp | +0.1% |
| XJR | iShares ESG Screened S&P Small-Cap ETF | 72.4% | -3 bp | -0.1% |
| VIOV | Vanguard S&P Small-Cap 600 Value ETF | 56.4% | -5 bp | +2.3% |
| SLYV | State Street SPDR S&P 600 Small Cap Value ETF | 55.7% | 0 bp | +2.4% |
| IJS | iShares S&P Small-Cap 600 Value ETF | 55.6% | +3 bp | +2.3% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 54.8% | -5 bp | -2.2% |
| RWJ | Invesco S&P SmallCap 600 Revenue ETF | 54.5% | +24 bp | +0.9% |
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 54.0% | 0 bp | -2.0% |
Risk and Returns: QVMS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 10/5/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.8%
ALTAR SCORE™
75th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,398 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. QVMS's ALTAR Score™ is approximately 0.7 standard
deviations above the category average. This places QVMS in the 75th percentile
among funds in the category.
Sell-Side Consensus
$38.09
PRICE TARGET
+16.9%
UPSIDE